Advanced Cell Diagnostics Gets $5.4M
Hayward-based Advanced Cell Diagnostics (ACD), a developer of cell- and tissue-based diagnostic tests for personalized medicine, announced late Wednesday that the firm has completed a second close on a $5.4M, Series A funding. The financing came from Morningside Ventures. ACD said the funding will go to accelerate development of the firm's diagnostic tests.
posted on Wednesday, September 2, 2009 (Link to more information)
Related companies:
Advanced Aero
Related stories:
> Advanced Cell Diagnostics Gains $12M
> Celera Acquired By Quest Diagnostics For $327M
> Kleiner Funds HX Diagnostics
> Two Pore Guys Gains $24.5M For Molecular Diagnostics
> Gene Security Network Snags $12M More
silicontap.com Home